Sorensen Mel

President and CEO at Galera Therapeutics, Inc.

Sold, on record
$6k
Dollars the filings state
Form 4 sales
2
Latest Nov 20, 2025
Form 144 notices
1
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 144 notice Galera Therapeutics, Inc.Notice
    Aug 16, 2024 2024

    Filed to sell 67,015 shares ($5k)

    Sorensen Mel, Officer, Director

    No 10b5-1 planFirst sale on recordFiling

  2. 2 Form 4 sale Galera Therapeutics, Inc.No plan
    Aug 16, 2024 same day

    Sold 67,015 shares at $0.0700 ($5k)

    Sorensen Mel, President and CEO

    No 10b5-1 planSold 20.2% of holdings ($23k position)265,029 shares leftFirst sale on recordFollows a Form 144Filing

  3. 3 Form 4 sale Galera Therapeutics, Inc.Unusual
    Nov 20, 2025 +461 days

    Sold 70,000 shares at $0.0200 ($1k)

    Sorensen Mel, President and CEO

    No 10b5-1 planSold 26.4% of holdings ($5k position)195,029 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Sorensen Mel
Source
Nov 20, 2025Nov 24, 2025Galera Therapeutics, Inc.President and CEOForm 4 sale70,000$1k26.4%UnusualSEC
Aug 16, 2024Aug 20, 2024Galera Therapeutics, Inc.President and CEOForm 4 sale67,015$5k20.2%No planSEC
Aug 16, 2024Aug 16, 2024Galera Therapeutics, Inc.Officer, DirectorForm 144 notice67,015$5kNoticeSEC